Thought Leader:

Bhaskar Sambasivan, Senior V.P. & Global Markets Leader, Cognizant Life Sciences

August 1, 2017

Bhaskar Sambasivan discusses how executives can leverage digital technologies, key areas of focus for Life Sciences companies, managing numerous aspects in the move towards patient-centricity, and how platforms can unlock new revenue streams and provide cost savings.

Thought Leader:

Jim Corrigan, President & CEO, ERT

August 1, 2017

Jim Corrigan discusses the risks associated with clinical trials, clearing the hurdle of paper in clinical research, the most promising and exciting advancements in the eclinical space, where the eclinical space will be five years from now, and the new era of collaboration.

Thought Leader:

Richard Scheyer, M.D. Vice President, Medical Affairs, Medpace

July 28, 2017

Richard Scheyer discusses the importance of patient-centricity in rare disease studies, the benefits of customized studies, connecting with key investigators, and the increased interest in rare diseases.

Thought Leader:

Matthew J. Neal, Senior Director, Product Management, Regulatory Solutions, PAREXEL

July 28, 2017

Matthew J. Neal discusses the biggest challenge that regulatory and clinical systems need to address, how technology can be used in this cause, how global health authorities are dealing with these issues, and how data is at the center of the movement towards patient-centrici … Read More »

Thought Leader:

Robert A. Carlson, MD, Vice President, Medical Affairs, ACM Global Laboratories

July 28, 2017

Robert A. Carlson, MD discusses digital pathology as it relates to clinical trials, how patients benefit, as well as the cause and effect of the diminishing number of pathologists.

Thought Leader:

Jeff Wendel, MBA, President & CEO, Chesapeake IRB

July 28, 2017

Jeff Wendel discusses how an IRB can streamline study startups, trends in regulatory and site identification, and working with academic medical centers to insure compliance with sIRB policy.

Thought Leader:

Staci McDonald PharmD, Executive Director, Scientific Clinical Operations, Celerion

July 26, 2017

Staci McDonald, PharmD discusses how Celerion’s business is changing with the emergence of biosimilar drugs, why biosimilar developers choose to work with Celerion, and what they have learned in the course of their biosimilar research.

Thought Leader:

Simon J. Griffin, CEO, Lifelines Neurodiagnostic Systems, Inc.

July 21, 2017

Simon J. Griffin discusses the merits of adding a Cloud-based video EEG component to a trial protocol, which therapeutic categories benefit the most from this, and how a Cloud strategy can improve recruitment and randomization goals.

Thought Leader:

David Connelly, CEO, Cmed

July 21, 2017

David Connelly discusses Cmed’s new Encapsia product, its benefits in the clinical trials process, how sponsors can use it, and its current availability.

Thought Leader:

Andrew Cassel, Managing Director, Data and Analytics, Medidata Solutions

July 21, 2017

Andrew Cassel discusses Machine Learning technology, and the practical applications of predictive modeling and genomics in clinical trials.

Thought Leader:

Judith Ng-Cashin, M.D. Chief Scientific Officer, INC Research

July 21, 2017

Judith Ng-Cashin discusses running clinical trials for rare diseases, including critical factors, engaging patients, additional stakeholders, and the growing amount of clinical research in the rare disease space.

Thought Leader:

Bill Byrom, Senior Director of Product Innovation, ICON

July 21, 2017

Bill Byrom discusses Bring-your-own-device (BYOD) adoption by patients in clinical trials, industry concerns, supporting evidence in favor of BYOD adoption, and thoughts on the next frontier in clinical trials.

Thought Leader:

Eric Delente, President, New Patient Solutions, DrugDev

July 21, 2017

Eric Delente discusses how eConsent differs from the traditional informed consent procedures, the barriers keeping some organizations from converting to digital, lessons learned regarding eConsent, and how eConsent can make monitoring easier.

Thought Leader:

Donald Deieso, Ph.D., Chairman & CEO, WIRB Copernicus Group

July 21, 2017

Donald A. Deieso PhD discusses the changing landscape for clinical and IRB services, transformative improvements in clinical research, the recent acquisitions by WIRB-Copernicus Group, and how their alliance with Huron is improving the efficiency of clinical trials.

Thought Leaders:

Alastair MacDonald, Executive Director, Real World and Late Phase
Janet Baldwin, Vice President, Real World and Late Phase"

July 21, 2017

Alastair MacDonald and Janet Baldwin discuss why Real World Evidence (RWE) is important today, insights on late-stage research, when companies should start thinking about RWE generation, recommendations on identifying and collecting RWE, and the future of RWE.

Thought Leader:

Scott Gray, CEO, Clincierge

July 19, 2017

Scott Gray discusses why recruiting a diverse patient base in clinical trials is important, the barriers to achieving patient diversity, tips for ensuring greater diversity among patients, the ROI for such practices, and an example of one of his success stories.

Thought Leader:

Jignesh Patel, Principal Scientist, Clinical Research, Cardinal Health Regulatory Sciences

July 19, 2017

Jignesh Patel discusses adaptive clinical trials, how this process relates to the FDA and the 21st Century Cures Act, its benefits and limitations, and when it should be used in clinical research.

Thought Leader:

Kevin Duffy, Global Vice President, Global Solutions, Life Sciences & Healthcare, Kelly OCG

July 19, 2017

Kevin Duffy discusses talent in the Life Sciences and Healthcare space, how to keep millennials on staff, and the impact of technology on talent.

Thought Leader:

Jason Casarella, Executive Vice President, Business Development and Marketing, Advanced Clinical

July 19, 2017

Jason Casarella discusses trends in the CRO market, challenges sponsors face today, how the industry is reponding to these challenges, and the rate of collaboration between companies in the industry.

Thought Leader:

Nicholas Kenny, PhD, Executive Vice President, Oncology & Hematology, INC Research

July 19, 2017

Nicholas Kenny discusses innovative trial designs, collaboration in clinical research, the impact of collaboration to INC Research, sites, and sponsors, and the evolution of immunotherapy and combination trials.

Thought Leader:

Peter Benton, President & COO, Worldwide Clinical Trials

July 19, 2017

Peter Benton discusses current trends in the CRO space, how Worldwide Clinical Trials is responding to these trends, challenges sponsors currently face, what the “Cure for the Common CRO” means, how to attract the best new talent through cultural changes, and how to address … Read More »

Thought Leader:

Andrew Schachter, CEO and Founder, Axiom Real-Time Metrics

July 19, 2017

Andrew Schachter discusses how small/mid-sized life sciences organizaions select EDC vendors, the concept of “Unified” in an eClinical suite, the pain points for end-users, and Axiom’s Fusion eClinical Suite.

Thought Leaders:

Donald Deieso, Ph.D., Chairman & CEO, WIRB-Copernicus Group
Edmundo Muniz, M.D., Ph.D., CEO, Certara

July 27, 2016

Donald Deieso, Ph.D., of WIRB-Copernicus Group and Edmundo Muniz, M.D., Ph.D., of Certara discuss some of the challenges facing the pharmaceutical industry today; what can be done to enhance the chances of drugs making it to market; and ways to improve patient access, accele … Read More »

Thought Leader:

Greg Skalicky, Chief Commercial Officer, inVentiv Health

July 27, 2016

Greg Skalicky of inVentiv Health discusses the various industry dynamics impacting clinical research, as well as why it’s important to marry the clinical and commercial sides of the business together.

Thought Leader:

Marty Anderson, Executive Director, Clinical Development, INC Research

July 27, 2016

Marty Anderson of INC Research discusses the unique challenges facing vaccine trials, and how to overcome them.

Thought Leader:

Brett Kleger, Chief Commercial Officer, DrugDev

July 27, 2016

Brett Kleger of DrugDev talks about collaboration, standardization, and bringing a beautiful technology experience into clinical research.

Thought Leader:

Peter Benton, President and COO, Worldwide Clinical Trials

July 27, 2016

Peter Benton of Worldwide Clinical Trials talks about the challenges facing clinical trial sponsors, where drug and device innovations will come from, and how to attract the best and brightest talent.

Thought Leader:

Kevin Duffy, Global VP, Life Sciences, KellyOCG

July 27, 2016

Kevin Duffy of KellyOCG outlines talent engagement obstacles in life-science organizations and the risks companies face by not having an evolving talent strategy.

Thought Leaders:

Kevin Bickford, Senior Director, Clinical Operations, ClinicalRM
Joseph Sgherza, President, ClinicalRM

July 27, 2016

Kevin Bickford and Joseph Sgherza of ClinicalRM discuss preparing for and responding to global health crises and pandemics, such as Zika and Ebola.

Thought Leader:

Scott Gray, CEO, Clincierge

July 27, 2016

Scott Gray of Clincierge discusses how to increase patient engagement in clinical trials, provides learnings from advocacy group surveys, and shares a recent success story on protocol innovations.

Thought Leaders:

Nita Ichhpurani, Senior Director, External Study Management, Drug Development Services, Celerion
Thomas Marbury, President, Orlando Clinical Research Center

July 27, 2016

Nita Ichhpurani of Celerion and Thomas Marbury of Orlando Clinical Research Center discuss pharmacokinetic studies for patients with renal and hepatic impairment, and how to overcome patient recruitment challenges for this type of clinical research.

Thought Leader:

Eric Valentine, Global Director, Clinical Distribution Services, Catalent Pharma Solutions

July 27, 2016

Eric Valentine of Catalent Pharma Solutions provides an overview of the company’s new FastChain demand-led supply model and how it improves the management of global clinical supplies.

Thought Leader:

Lee Walke, VP eClinical/Real World Evidence, Medpace

July 27, 2016

Lee Walke of Medpace discusses how eClinical systems are evolving to support risk-based monitoring, how to keep patients engaged, and what it will take to make eSource a reality.

Thought Leader:

Sy Pretorius, Chief Scientific Officer, PAREXEL

July 27, 2016

Sy Pretorius of PAREXEL talks about key industry hot topics — adaptive study design personalized medicine patient recruitment, mHealth technology and data, and accelerated pathway approvals — and how PAREXEL is addressing these trends.

Thought Leader:

Brian Schaechter, Vice President, Clinical Trial Division, Artcraft Health

July 27, 2016

Brian Schaechter of Artcraft Health shares trends in patient centricity and the impact of patient education on clinical trials.

Thought Leader:

Patrick Lindsay, President, UBC

July 27, 2016

Patrick Lindsay of UBC explains why recognizing the important contributions being made by the “heros” in the biopharmaceutical industry who tirelessly fight disease and improve patient lives is so important, and outlines some of the most significant recent achievements in th … Read More »

Thought Leader:

Sonja VanWye, Director, Clinical Operations Head of Project Management, TKL Research

July 27, 2016

Sonja VanWye of TKL Research talks about the challenges in creating a successful sponsor/CRO relationship, the benefits of partnering with a CRO instead of maintaining the process in-house, and what capabilities sponsors should look for in a CRO.

Thought Leader:

Kara Dennis, Managing Director, Mobile Health, Medidata Solutions Worldwide

July 27, 2016

Kara Dennis of Medidata Solutions Worldwide discusses how mHealth technology, such as wearables, sensors, and apps, are positiviely impacting clinical trials and the benefits of harnessing the new types of data being collected.

Thought Leader:

John Herzig, Regional Sales Director, Lionbridge Life Sciences

July 27, 2016

John Herzig of Lionbridge Life Sciences talks about trends in the life sciences, managing today’s greatest challenges, and how technology is helping overcome these challenges.

Thought Leader:

Jill McGuinn, VP, Biotechnology Strategy, INC Research

July 27, 2016

Jill McGuinn of INC Research talks about clinical development challenges in biotechnology, strategies to overcome these obstacles, and keys to a successful CRO-biotech partnership.

Thought Leader:

Jonathan Andrus, Chief Data & Privacy Officer, Clinical Ink

July 27, 2016

Jonathan Andrus of Clinical Ink talks about improving the clinical trial experience by using eSource, and how the technology is a game changer for data management and monitoring.

Thought Leader:

Eric Morrie, Director of Product Operations, ClinCapture

July 27, 2016

Eric Morrie of ClinCapture talks about the evolving eClinical industry, including disruptive solutions in clinical research technology.

Thought Leader:

Adam Butler, Senior VP, Strategic Development and Corporate Marketing, Bracket

July 27, 2016

Adam Butler of Bracket talks about using technology to improve patient engagement in clinical trials.

Thought Leader:

Dr. Martine Dehlinger-Kremer, Global VP and Regulatory Affairs, SynteractHCR

July 27, 2016

Dr. Martine Dehlinger-Kremer of SynteractHCR discusses the advantages of the new EU clinical trial regulation intended to streamline the clinical trial approval process by simplifying the authorization process, which is set to come into force at the end of 2017, and its rele … Read More »

Thought Leaders:

Matt Kibby, President and Chief Innovation Officer, BBK Worldwide
Thomas Klein, Founder and CEO, Be the Partner

July 27, 2016

Matt Kibby of BBK Worldwide and Thomas Klein of Be the Partner discuss the new connected mHealth model for increasing patient engagement and other clinical research benefits.

Thought Leader:

Cheryle Evans, Senior VP, Clinical & Medical Operations, Advanced Clinical

July 27, 2016

Cheryle Evans of Advanced Clinical discusses designing and implementing a risk-based monitoring program.

Thought Leader:

Dr. Hendrik Arend Kroon, Chief Medical Officer and Executive VP, Hallux

March 31, 2016

The California-based pharmaceutical company is developing a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis (toenail fungus). “We are currently testing in the clinic using the ClinCapture EDC system” explains Hendrik Arend … Read More »

Thought Leader:

Luke VanHengel, Corporate Vice President of Business Operations, PAREXEL Clinical Research Services

November 1, 2015

PAREXEL Clinical Research Services, Corporate Vice President of Business Operations Luke VanHengel discusses his company’s comprehensive clinical research services, which range from First-in-Human through Phase IV and Post-marketing follow-through. PAREXEL has the regulatory … Read More »

Thought Leaders:

PharmaVOICE 100 Honorees

October 21, 2015

Against the backdrop of New York City’s elegant and high-tech Alexandria Center for Life Science, this year’s PharmaVOICE 100 Celebration brought together the most inspirational and influential leaders from across all sectors of the life-sciences industry. This Celebration e … Read More »

Thought Leaders:

PharmaVOICE 100 Honorees

October 21, 2015

Against the backdrop of New York City’s elegant and high-tech Alexandria Center for Life Science, this year’s PharmaVOICE 100 Celebration brought together the most inspirational and influential leaders from across all sectors of the life-sciences industry. This Celebration e … Read More »

Thought Leader:

Alex Gorsky, Chairman & CEO, Johnson & Johnson

October 14, 2015

Alex Gorsky, Chairman and CEO of Johnson & Johnson, talks about the PharmaVOICE 100 honorees and how Johnson & Johnson is working to deliver better health care to the world.

Thought Leader:

Sandra Lottes, PharmD, VP, Global Clinical Development and Operations, United BioSource Corp., an Express Scripts Company

September 1, 2015

Sandra R. Lottes, PharmD, discusses what she brings to her team to inspire them to do great work.

Thought Leader:

Kara Dennis, Managing Director of Mobile Health, Medidata Solutions

September 1, 2015

Kara Dennis shares ways she inspires her team, and the things that inspire her in her work.

Thought Leader:

Dr. Jules Mitchel, President, TargetHealth Inc.

August 31, 2015

Dr. Jules Mitchel shares what it’s like being an inspiration to the industry, how he inspires his team and peers, who has inspired him, and the innovations he is seeing in the industry.

Thought Leader:

Patrick Hughes, Chief Commercial Officer, CluePoints

August 31, 2015

Patrick Hughes discusses how he inspires his team and what inspires him in his career.

Thought Leader:

Thomas Wicks, Chief Strategy Officer, TrialScope, Inc.

August 31, 2015

Thomas Wicks tells us how he inspires his team, and where he receives inspiration.

Thought Leader:

Stephen Smith, Chief Patient Advocate, Medidata Solutions

August 31, 2015

Stephen Smith shares ways he inspires his team, his work on HR6, why he is passionate about rare diseases, and his hope for the future for rare diseases.

Thought Leader:

Ken Faulkner, Corporate VP, PAREXEL Informatics

August 13, 2015

PAREXEL® Informatics, Corporate Vice President Ken Faulkner discusses his company’s unique Perceptive® MyTrials solution. All along your new drug’s development path, PAREXEL® Informatics has technological innovations that make the process faster, more precise, more trackable … Read More »

Thought Leader:

Mark Lanfear, Global Practice Lead - Life Science Solutions, Kelly Outsourcing and Consulting Group

August 12, 2015

Mark Lanfear of Kelly Outsourcing and Consulting Group discusses the evolving clinical trial landscape and how the talent needs within the industry are changing.

Thought Leader:

Ben McGraw, Strategic Marketing - Informatics, PerkinElmer

August 12, 2015

Ben McGraw of PerkinElmer discusses various trends impacting the industry from IT to data transparency and the pros and cons of virtual biotech models.

Thought Leader:

Mark Engelhart, Chief Commercial Officer, ACM Global Central Laboratory

July 30, 2015

Mark Engelhart of ACM discusses clinical trials protocols, diagnostic testing, risk-based monitoring, and adaptive trials.

Thought Leader:

David Burnham, VP, Strategic Alliance Management, INC Research

July 29, 2015

David Burnham explores ways to improve the CRO-sponsor relationship and the associated benefits of a partnership alliance and successful strategic CRO-sponsor collaboration.

Thought Leader:

Andrew Townshend, Senior VP, Alliance Development, INC Research

July 29, 2015

Andrew Townshend outlines the key benefits of a strategic CRO-sponsor alliance and ways to maximize the expertise from one project to the next.

Thought Leader:

Kent Thoelke, Executive VP, Scientific and Medical Affairs, Safety and Commercialization Services, PRA Health Sciences

July 29, 2015

Kent Thoelke talks about the impact that big data will have on innovation in the clinical trial space and how to leverage data to more efficiently get new drugs to market.

Thought Leader:

Kara Dennis, Managing Director of Mobile Health, Medidata

July 29, 2015

Kara Dennis talks about how sensors, wearables, and apps within clincial trials will lead to better data and better science.

Thought Leader:

Larry Florin, Clinical Leader, Life Sciences R&D Practice, Cognizant

July 29, 2015

Larry Florin defines “Code Halos” and how they are transforming clinical development and how digital clinical data impacts analytics, analysis, and decision-making.

Thought Leaders:

Marc Sirockman, Executive VP & General Manager, Artcraft Health
Brian Schaechter, Senior Director, Clinical Trials Division, Artcraft Health

July 29, 2015

Marc Sirockman and Brian Schaechter reveal trends in the clinical development space, how to measure the ROI of technology, and the challenges of leveraging new technologies.

Thought Leaders:

Bonnie A. Brescia, Founding Principal, BBK Worldwide
Christel Marchand Aprigliano, CEO, The Diabetes Collective

July 29, 2015

Bonnie Brescia and Christel Aprigliano discuss the past, present, and future of patient centricity.

Thought Leaders:

Bonnie A. Brescia, Founding Principal, BBK Worldwide
Claire Meunier, Vice President, Research Engagement, Michael J. Fox Foundation

July 29, 2015

Bonnie Brescia and Claire Meunier talk about integrating the patient voice in clinical research, and how wearables, ingestibles, and other technologies are supporting patient centricity.

Thought Leader:

David Laky, General Manager, Clinical, ArisGlobal

July 29, 2015

David Laky provides an overview on integrated solutions in clinical development systems and their impact on the future of clinical research.

Thought Leaders:

J. Fredrick Pritchard Ph.D., Vice President, Global Drug Development, Celerion
Deborah Chee M.D., Ph.D., President, KoNECT

July 29, 2015

Drs. Pritchard and Chee discuss Celerion’s expansion into South Korea, KoNECT’s role in fostering clinical research in South Korea, and the advantages of conducting clinical research in South Korea.

Thought Leader:

Jamie Powers, Principal Consultant, SAS Health & Life Sciences

July 29, 2015

Dr. Jamie Powers outlines how biopharmaceutical companies can best use real-world data sources and how to use data analytics to maximize the value of data points.

Thought Leader:

Lynn King, Senior Director, Clinical Monitoring, TKL Research, Inc.

July 29, 2015

Lynn King shares some misconceptions about risk-based monitoring and offers alternative clinical monitoring strategies using RBM.

Thought Leaders:

Michael Pollock, Vice President of Real-world Outcomes, PPD
Mark Cziraky, Vice President of Research, HealthCore

July 29, 2015

Michael Pollock and Mark Cziraky discuss how their two companies’ recent collaboration and combined strengths will improve real-world outcomes/evidence and Phase IV pragmatic trials.

Thought Leader:

Sandra Lottes, PharmD, VP, Global Clinical Development & Operations, United BioSource Corporation

July 29, 2015

Dr. Sandra Lottes shares insights on various issues related to oncology-based clinical research.

Thought Leader:

Bill Gwinn, VP, Clinical Informatics Solutions, Optum

July 29, 2015

Bill Gwinn discusses how the explosion of new data points is impacting the industry and the importance of analytics to make a wide array of strategic decisions based on the new information available.

Thought Leader:

Peter Benton, President & Chief Operating Officer, Worldwide Clinical Trials

July 29, 2015

Peter Benton describes the growth of start-up biotech and pharma companies, how evidenced-based value impacts a portfolio’s value, and keeping the focus on the patient.

Thought Leader:

Kathryn King, Vice President, Vault Clinical, Veeva

July 29, 2015

Kathryn King of Veeva shares findings from Veeva’s second annual Paperless TMF Survey.

Thought Leader:

Dr. Donald A. Deieso, Ph.D., Chairman and CEO, WIRB-Copernicus Group

July 29, 2015

Dr. Deieso discusses the most significant changes in drug development, new opportunities, and how precision medicine is impacting adaptive trials.

Thought Leader:

Zaher El-Assi, President, Merge eClinical

July 29, 2015

Zaher El-Assi discusses EDC consolidation, the adoption of adaptive trial designs, ways to minimize trial risk, and industry innovation.

Thought Leader:

Bill Cooney, President & CEO, MedPoint Digital

July 29, 2015

Bill Cooney discusses how studies are becoming digital, how this impacts clinical research subjects, and how the industry needs to adapt.

Thought Leader:

Michelle Petersen, Clinical Trial Manager, Medpace

July 29, 2015

Michelle Petersen of Medpace discusses why rare disease and orphan indications are unique, related challenges to development, and tips for common study execution.

Thought Leader:

Gregory Skalicky, Chief Commercial Officer, inVentiv Health Clinical

July 29, 2015

Gregory Skalicky discusses the evolution of strategic engagements with sponsors and the benefits of working with a full-service, global CRO.

Thought Leader:

Ira Spector, Ph.D., Executive VP, Analytics & Consulting, ICON

July 29, 2015

Dr. Spector describes how the R&D model will change by 2025, the void in clinical research talent, and preparing for the future.

Thought Leader:

Margaret Hurley, M.D., President & CEO, Hurley Consulting Associates Ltd.

July 29, 2015

Dr. Hurley discusses regulatory challenges in an era of mergers and acquisitions, FDA review practices, and managing the FDA approval process.

Thought Leader:

Jeffrey Kasher, Ph.D., Advisory Board Chairman, DrugDev

July 29, 2015

Dr. Kasher tells us why he became Advisory Board Chairman of DrugDev and shares his thoughts what the industry needs to do to fulfill its duty to patients worldwide and his take on technology’s role in changing the industry.

Thought Leader:

Abhishek Shankar, Vice President & Head, Life Sciences, North America, HCL Technologies

July 29, 2015

Abhishek Shankar discusses the value of patient-centricity and and how the cloud is transforming operations in the life-sciences industry.

Thought Leader:

Jim Nichols, VP, US Operations & Life Sciences, DitaExchange

July 29, 2015

Jim Nichols provides an overview of structured content management (SCM) and why it’s important; he also shares examples and metrics of projects and outlines the next step in the evolution of SCM.

Thought Leader:

Joseph Sgherza, Senior VP Global Operations, ClinicalRM

July 29, 2015

Joseph Sgherza outlines global trends related to clinical trials for pandemic responses, innovations in logistics, and how ClinicalRM assists in pandemic situations.

Thought Leader:

Jim Esinhart, Ph.D., CEO, Chiltern International,Inc.

July 29, 2015

Dr. Esinhart discusses how Chiltern’s “Designed Around You” culture supports clients’ needs, the advantages of a mid-sized global CRO, and how technology is changing the industry.

Thought Leader:

Julie Ross, Executive Vice President, CRO, Advanced Clinical

July 29, 2015

Julie Ross provides insights into how small pharma, biotech, and device companies can find the right development partner; how eTMF and business process automation affect clinical trials; and how social media is impacting patient recruitment.

FEEDBACK